Still a valid viewpoint
Post in a year from now ….with a bit of deeper analysis
https://www.fiercepharma.com/pharma/fda-staff-cuts-could-hinder-drug-reviews-putting-agencys-critical-user-fee-programs-risk
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-176
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.84 |
Change
-0.025(1.34%) |
Mkt cap ! $2.335B | |||
| Open | High | Low | Value | Volume |
| $1.88 | $1.94 | $1.82 | $10.58M | 5.682M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6520 | $2.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.66 | 12333 | 3 |
View Market Depth
| Last trade - 15.59pm 17/06/2025 (20 minute delay) ? |
| MSB (ASX) Chart |